Deepak Malik

Congratulations for a good set of numbers. Sir, my first question is on the CDMO business. Can you please highlight what drove this strong growth in this quarter? Is it like human CDMO? Or was it animal in this quarter? So what actually drove the performance? And is it sustainable for quarter 4?

In this human health and animal health, has there any new capacity which go ne into commercialization? Or was it a new product which got launched? So what actually -- if you can give a little more colour on exactly -- so what exactly led to this kind of strong growth, launch of new products, the commercialization of new facility or ramp-up of existing contracts

Okay, sir. And you think this is something which will further scale up going forward from Q4 and Q1 and Q2? So this is like just the start and then things will further scale up from here onwards?

Congratulations for a good set of numbers. Sir, my first question is on the CDMO business. Can you please highlight what drove this strong growth in this quarter? Is it like human CDMO? Or was it animal in this quarter? So what actually drove the performance? And is it sustainable for quarter 4?

In this human health and animal health, has there any new capacity which go ne into commercialization? Or was it a new product which got launched? So what actually -- if you can give a little more colour on exactly -- so what exactly led to this kind of strong growth, launch of new products, the commercialization of new facility or ramp-up of existing contracts

Okay, sir. And you think this is something which will further scale up going forward from Q4 and Q1 and Q2? So this is like just the start and then things will further scale up from here onwards?